Nitric Oxide Completed Phase 3 Trials for Prematurity, Respiratory Distress Syndrome,Hypoxemia Prevention

IndicationsStatusPurposePhase
CompletedPrevention3
clinicaltrials.gov IdentifierTitleDrugs
NCT00152542Follow-up at School-age of Children Who Participated in the Efficacy Study of Nitric Oxide for Premature Infants